In this multicenter longitudinal prospective study, we hypothesized that chronic inflammation is responsible for the increased aPWV previously reported in patients with IBD and that anti‐TNFα drugs could reduce aPWV. This evidence concerns the gene TNF and inflammatory bowel disease.